{"entity":{"type":"insider","cik":"0001687509","url":"/insider/0001687509","json_url":"/insider/0001687509.json","name":"Rubric Capital Management LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":43,"n_filings":16,"first":"2021-12-10","last":"2025-08-15","span_basis":"filed_date"},"name_variants":[{"name":"Rubric Capital Management LP","source":"filing","n_filings":16,"first_seen":"2021-12-10","last_seen":"2025-08-15"}],"transactions":[{"id":5104687,"accession":"0000902664-25-003729","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-25-003729","line_url":"/filing/0000902664-25-003729#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":null,"owner_name":"Rosen David Efraim; Rubric Capital Management LP","owner_display_name":"Rosen David Efraim","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":37.85,"price_display":"37.85","price_state":"stated","total_value":946250.0,"total_display":"946,250.00","total_whole":"946,250","shares_owned_after":3132743.0,"shares_owned_after_display":"3,132,743","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-13","filed_date":"2025-08-15","scope":"insider"},{"id":4090867,"accession":"0000902664-25-003535","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-25-003535","line_url":"/filing/0000902664-25-003535#line-1","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":null,"owner_name":"Rosen David Efraim; Rubric Capital Management LP","owner_display_name":"Rosen David Efraim","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2387225.0,"shares_display":"2,387,225","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":3580837.5,"total_display":"3,580,837.50","total_whole":"3,580,838","shares_owned_after":29100728.0,"shares_owned_after_display":"29,100,728","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-08","filed_date":"2025-08-12","scope":"insider"},{"id":4226422,"accession":"0000902664-25-002832","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0000902664-25-002832","line_url":"/filing/0000902664-25-002832","is_derivative":false,"issuer_cik":"0001622536","issuer_name":"Talen Energy Corp","issuer_ticker":"TLN","issuer_name_source":null,"issuer_url":"/issuer/0001622536","owner_cik":null,"owner_name":"Rubric Capital Management LP; Rosen David Efraim","owner_display_name":"Rubric Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":178000.0,"shares_display":"178,000","price_per_share":296.0431674185393,"price_display":"296.04","price_state":"stated","total_value":52695683.8005,"total_display":"52,695,683.80","total_whole":"52,695,684","shares_owned_after":5762010.0,"shares_owned_after_display":"5,762,010","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-27","filed_date":"2025-06-27","scope":"insider","n_lines":7},{"id":4226373,"accession":"0000902664-25-002832","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000902664-25-002832","line_url":"/filing/0000902664-25-002832","is_derivative":false,"issuer_cik":"0001622536","issuer_name":"Talen Energy Corp","issuer_ticker":"TLN","issuer_name_source":null,"issuer_url":"/issuer/0001622536","owner_cik":null,"owner_name":"Rubric Capital Management LP; Rosen David Efraim","owner_display_name":"Rubric Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":102217.0,"shares_display":"102,217","price_per_share":291.98482933954233,"price_display":"291.98","price_state":"stated","total_value":29845813.3006,"total_display":"29,845,813.30","total_whole":"29,845,813","shares_owned_after":5945994.0,"shares_owned_after_display":"5,945,994","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-26","filed_date":"2025-06-27","scope":"insider","n_lines":6},{"id":4226348,"accession":"0000902664-25-002832","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000902664-25-002832","line_url":"/filing/0000902664-25-002832","is_derivative":false,"issuer_cik":"0001622536","issuer_name":"Talen Energy Corp","issuer_ticker":"TLN","issuer_name_source":null,"issuer_url":"/issuer/0001622536","owner_cik":null,"owner_name":"Rubric Capital Management LP; Rosen David Efraim","owner_display_name":"Rubric Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share (\"Common Stock\")","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":108313.0,"shares_display":"108,313","price_per_share":291.289987738314,"price_display":"291.29","price_state":"stated","total_value":31550492.4419,"total_display":"31,550,492.44","total_whole":"31,550,492","shares_owned_after":6079157.0,"shares_owned_after_display":"6,079,157","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-25","filed_date":"2025-06-27","scope":"insider","n_lines":8},{"id":2354403,"accession":"0001104659-24-128881","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-128881","line_url":"/filing/0001104659-24-128881#line-2","is_derivative":false,"issuer_cik":"0001622536","issuer_name":"Talen Energy Corp","issuer_ticker":"TLN","issuer_name_source":null,"issuer_url":"/issuer/0001622536","owner_cik":null,"owner_name":"Rosen David Efraim; Rubric Capital Management LP","owner_display_name":"Rosen David Efraim","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share (\"Common Stock\")","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4893507.0,"shares_display":"4,893,507","price_per_share":204.3524,"price_display":"204.35","price_state":"stated","total_value":999999899.8668,"total_display":"999,999,899.87","total_whole":"999,999,900","shares_owned_after":6475107.0,"shares_owned_after_display":"6,475,107","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-13","filed_date":"2024-12-16","scope":"insider"},{"id":8051891,"accession":"0001104659-23-000311","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-000311","line_url":"/filing/0001104659-23-000311#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":null,"owner_name":"Rubric Capital Management LP; Rosen David Efraim","owner_display_name":"Rubric Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Series A Preferred Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29000.0,"shares_display":"29,000","price_per_share":1333.0,"price_display":"1,333.00","price_state":"stated","total_value":38657000.0,"total_display":"38,657,000.00","total_whole":"38,657,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-30","filed_date":"2023-01-03","scope":"insider"},{"id":6172088,"accession":"0001104659-22-126117","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-126117","line_url":"/filing/0001104659-22-126117#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":null,"owner_name":"Rosen David Efraim; Rubric Capital Management LP","owner_display_name":"Rosen David Efraim","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14825.0,"shares_display":"14,825","price_per_share":6.09,"price_display":"6.09","price_state":"stated","total_value":90284.25,"total_display":"90,284.25","total_whole":"90,284","shares_owned_after":1757191.0,"shares_owned_after_display":"1,757,191","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-09","filed_date":"2022-12-12","scope":"insider"},{"id":6366230,"accession":"0001104659-22-125712","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-125712","line_url":"/filing/0001104659-22-125712#line-2","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":null,"owner_name":"Rubric Capital Management LP; Rosen David Efraim","owner_display_name":"Rubric Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":5.83,"price_display":"5.83","price_state":"stated","total_value":1749.0,"total_display":"1,749.00","total_whole":"1,749","shares_owned_after":1742366.0,"shares_owned_after_display":"1,742,366","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-08","filed_date":"2022-12-09","scope":"insider"},{"id":6366229,"accession":"0001104659-22-125712","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-125712","line_url":"/filing/0001104659-22-125712#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":null,"owner_name":"Rubric Capital Management LP; Rosen David Efraim","owner_display_name":"Rubric Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20113.0,"shares_display":"20,113","price_per_share":5.6625,"price_display":"5.66","price_state":"stated","total_value":113889.8625,"total_display":"113,889.86","total_whole":"113,890","shares_owned_after":1742066.0,"shares_owned_after_display":"1,742,066","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-07","filed_date":"2022-12-09","scope":"insider"},{"id":6598298,"accession":"0001104659-22-112801","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-112801","line_url":"/filing/0001104659-22-112801#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":null,"owner_name":"Rubric Capital Management LP; Rosen David Efraim","owner_display_name":"Rubric Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Series A Preferred Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":1000.0,"price_display":"1,000.00","price_state":"stated","total_value":7000000.0,"total_display":"7,000,000.00","total_whole":"7,000,000","shares_owned_after":29000.0,"shares_owned_after_display":"29,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-28","filed_date":"2022-10-31","scope":"insider"},{"id":6598247,"accession":"0001104659-22-105392","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-105392","line_url":"/filing/0001104659-22-105392#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":null,"owner_name":"Rubric Capital Management LP; Rosen David Efraim","owner_display_name":"Rubric Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Series A Preferred Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":1000.0,"price_display":"1,000.00","price_state":"stated","total_value":7000000.0,"total_display":"7,000,000.00","total_whole":"7,000,000","shares_owned_after":22000.0,"shares_owned_after_display":"22,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-30","filed_date":"2022-10-03","scope":"insider"},{"id":6770820,"accession":"0001104659-22-089894","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-089894","line_url":"/filing/0001104659-22-089894#line-1","is_derivative":false,"issuer_cik":"0001428522","issuer_name":"Radius Health, Inc.","issuer_ticker":"RDUS","issuer_name_source":null,"issuer_url":"/issuer/0001428522","owner_cik":null,"owner_name":"Rubric Capital Management LP; Rosen David Efraim","owner_display_name":"Rubric Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1678954.0,"shares_display":"1,678,954","price_per_share":10.07,"price_display":"10.07","price_state":"stated","total_value":16907066.78,"total_display":"16,907,066.78","total_whole":"16,907,067","shares_owned_after":8642271.0,"shares_owned_after_display":"8,642,271","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-11","filed_date":"2022-08-12","scope":"insider"},{"id":6636634,"accession":"0001104659-22-089124","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-089124","line_url":"/filing/0001104659-22-089124#line-1","is_derivative":false,"issuer_cik":"0001428522","issuer_name":"Radius Health, Inc.","issuer_ticker":"RDUS","issuer_name_source":null,"issuer_url":"/issuer/0001428522","owner_cik":null,"owner_name":"Rosen David Efraim; Rubric Capital Management LP","owner_display_name":"Rosen David Efraim","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4012.0,"shares_display":"4,012","price_per_share":10.07,"price_display":"10.07","price_state":"stated","total_value":40400.84,"total_display":"40,400.84","total_whole":"40,401","shares_owned_after":6963317.0,"shares_owned_after_display":"6,963,317","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-10","filed_date":"2022-08-11","scope":"insider"},{"id":6214781,"accession":"0001104659-22-084850","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-084850","line_url":"/filing/0001104659-22-084850","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":null,"owner_name":"Rosen David Efraim; Rubric Capital Management LP","owner_display_name":"Rosen David Efraim","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Series A Preferred Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":580000.0,"shares_display":"580,000","price_per_share":25.86198275862069,"price_display":"25.86","price_state":"stated","total_value":14999950.0,"total_display":"14,999,950.00","total_whole":"14,999,950","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-29","filed_date":"2022-08-01","scope":"insider","n_lines":2},{"id":6125077,"accession":"0001104659-22-080754","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-080754","line_url":"/filing/0001104659-22-080754#line-2","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":null,"owner_name":"Rubric Capital Management LP; Rosen David Efraim","owner_display_name":"Rubric Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17688.0,"shares_display":"17,688","price_per_share":6.03,"price_display":"6.03","price_state":"stated","total_value":106658.64,"total_display":"106,658.64","total_whole":"106,659","shares_owned_after":1156953.0,"shares_owned_after_display":"1,156,953","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-18","filed_date":"2022-07-19","scope":"insider"},{"id":6125074,"accession":"0001104659-22-080754","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-080754","line_url":"/filing/0001104659-22-080754#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":null,"owner_name":"Rubric Capital Management LP; Rosen David Efraim","owner_display_name":"Rubric Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":64892.0,"shares_display":"64,892","price_per_share":5.56,"price_display":"5.56","price_state":"stated","total_value":360799.52,"total_display":"360,799.52","total_whole":"360,800","shares_owned_after":1139265.0,"shares_owned_after_display":"1,139,265","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-15","filed_date":"2022-07-19","scope":"insider"},{"id":5460310,"accession":"0001104659-21-150598","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-150598","line_url":"/filing/0001104659-21-150598#line-1","is_derivative":false,"issuer_cik":"0001428522","issuer_name":"Radius Health, Inc.","issuer_ticker":"RDUS","issuer_name_source":null,"issuer_url":"/issuer/0001428522","owner_cik":null,"owner_name":"Rosen David Efraim; Rubric Capital Management LP","owner_display_name":"Rosen David Efraim","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":146685.0,"shares_display":"146,685","price_per_share":7.0747,"price_display":"7.07","price_state":"stated","total_value":1037752.3695,"total_display":"1,037,752.37","total_whole":"1,037,752","shares_owned_after":6959305.0,"shares_owned_after_display":"6,959,305","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-16","filed_date":"2021-12-16","scope":"insider"},{"id":4515201,"accession":"0001104659-21-150068","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-150068","line_url":"/filing/0001104659-21-150068#line-3","is_derivative":false,"issuer_cik":"0001428522","issuer_name":"Radius Health, Inc.","issuer_ticker":"RDUS","issuer_name_source":null,"issuer_url":"/issuer/0001428522","owner_cik":null,"owner_name":"Rubric Capital Management LP; Rosen David Efraim","owner_display_name":"Rubric Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":180744.0,"shares_display":"180,744","price_per_share":6.77,"price_display":"6.77","price_state":"stated","total_value":1223636.88,"total_display":"1,223,636.88","total_whole":"1,223,637","shares_owned_after":6812620.0,"shares_owned_after_display":"6,812,620","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-15","filed_date":"2021-12-15","scope":"insider"},{"id":4515198,"accession":"0001104659-21-150068","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-150068","line_url":"/filing/0001104659-21-150068#line-2","is_derivative":false,"issuer_cik":"0001428522","issuer_name":"Radius Health, Inc.","issuer_ticker":"RDUS","issuer_name_source":null,"issuer_url":"/issuer/0001428522","owner_cik":null,"owner_name":"Rubric Capital Management LP; Rosen David Efraim","owner_display_name":"Rubric Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":94103.0,"shares_display":"94,103","price_per_share":6.811,"price_display":"6.81","price_state":"stated","total_value":640935.533,"total_display":"640,935.53","total_whole":"640,936","shares_owned_after":6631876.0,"shares_owned_after_display":"6,631,876","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-14","filed_date":"2021-12-15","scope":"insider"},{"id":4515191,"accession":"0001104659-21-150068","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-150068","line_url":"/filing/0001104659-21-150068#line-1","is_derivative":false,"issuer_cik":"0001428522","issuer_name":"Radius Health, Inc.","issuer_ticker":"RDUS","issuer_name_source":null,"issuer_url":"/issuer/0001428522","owner_cik":null,"owner_name":"Rubric Capital Management LP; Rosen David Efraim","owner_display_name":"Rubric Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":187391.0,"shares_display":"187,391","price_per_share":7.0804,"price_display":"7.08","price_state":"stated","total_value":1326803.2364,"total_display":"1,326,803.24","total_whole":"1,326,803","shares_owned_after":6537773.0,"shares_owned_after_display":"6,537,773","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-13","filed_date":"2021-12-15","scope":"insider"},{"id":4366452,"accession":"0001104659-21-148720","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-148720","line_url":"/filing/0001104659-21-148720#line-3","is_derivative":false,"issuer_cik":"0001428522","issuer_name":"Radius Health, Inc.","issuer_ticker":"RDUS","issuer_name_source":null,"issuer_url":"/issuer/0001428522","owner_cik":null,"owner_name":"Rosen David Efraim; Rubric Capital Management LP","owner_display_name":"Rosen David Efraim","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":768171.0,"shares_display":"768,171","price_per_share":7.175,"price_display":"7.18","price_state":"stated","total_value":5511626.925,"total_display":"5,511,626.92","total_whole":"5,511,627","shares_owned_after":6350382.0,"shares_owned_after_display":"6,350,382","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-10","filed_date":"2021-12-10","scope":"insider"},{"id":4366447,"accession":"0001104659-21-148720","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-148720","line_url":"/filing/0001104659-21-148720#line-2","is_derivative":false,"issuer_cik":"0001428522","issuer_name":"Radius Health, Inc.","issuer_ticker":"RDUS","issuer_name_source":null,"issuer_url":"/issuer/0001428522","owner_cik":null,"owner_name":"Rosen David Efraim; Rubric Capital Management LP","owner_display_name":"Rosen David Efraim","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":264644.0,"shares_display":"264,644","price_per_share":7.5841,"price_display":"7.58","price_state":"stated","total_value":2007086.5604,"total_display":"2,007,086.56","total_whole":"2,007,087","shares_owned_after":5582211.0,"shares_owned_after_display":"5,582,211","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-09","filed_date":"2021-12-10","scope":"insider"},{"id":4366444,"accession":"0001104659-21-148720","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-148720","line_url":"/filing/0001104659-21-148720#line-1","is_derivative":false,"issuer_cik":"0001428522","issuer_name":"Radius Health, Inc.","issuer_ticker":"RDUS","issuer_name_source":null,"issuer_url":"/issuer/0001428522","owner_cik":null,"owner_name":"Rosen David Efraim; Rubric Capital Management LP","owner_display_name":"Rosen David Efraim","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":560691.0,"shares_display":"560,691","price_per_share":8.0206,"price_display":"8.02","price_state":"stated","total_value":4497078.2346,"total_display":"4,497,078.23","total_whole":"4,497,078","shares_owned_after":5317567.0,"shares_owned_after_display":"5,317,567","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-08","filed_date":"2021-12-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001267565","name":"COLLEGIUM PHARMACEUTICAL, INC","url":"/issuer/0001267565","role":"Ten percent owner","n_filings":1,"first_seen":"2025-08-15","last_seen":"2025-08-15"},{"type":"issuer","type_label":"ISSUER","cik":"0000818033","name":"HERON THERAPEUTICS, INC. /DE/","url":"/issuer/0000818033","role":"Ten percent owner","n_filings":1,"first_seen":"2025-08-12","last_seen":"2025-08-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001622536","name":"Talen Energy Corp","url":"/issuer/0001622536","role":"Ten percent owner","n_filings":2,"first_seen":"2024-12-16","last_seen":"2025-06-27"},{"type":"issuer","type_label":"ISSUER","cik":"0000025743","name":"TherapeuticsMD, Inc.","url":"/issuer/0000025743","role":"Ten percent owner","n_filings":7,"first_seen":"2022-07-19","last_seen":"2023-01-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001428522","name":"Radius Health, Inc.","url":"/issuer/0001428522","role":"Ten percent owner","n_filings":5,"first_seen":"2021-12-10","last_seen":"2022-08-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001687509","retrieved_at":"2026-08-24T19:35:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}